Stocks
Sol-Gel Technologies Ltd.SLGL
NASDAQHealthcareBiotechnology$60.74
Price as of · delayed, not real-time
A clinical-stage dermatology company developing topical treatments for skin conditions, including acne and psoriasis. Its lead product candidates leverage a silica-based drug delivery platform to improve efficacy and tolerability. Investors track SLGL for its pipeline progress and partnership with Perrigo on commercial-stage products.
52W Range: $27.00-$97.97
Congressional Interest in Sol-Gel Technologies Ltd. (SLGL)
1 member of Congress has disclosed 1 trade in Sol-Gel Technologies Ltd. (SLGL), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading SLGL?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-08-03 | MICHAEL T. MCCAUL | buy | $1K-$15K |